Related Experiment Videos
Anticonvulsant efficacy of gabapentin on kindling in the immature brain
F A Lado1, E F Sperber, S L Moshé
1Department of Neurology, Albert Einstein College of Medicine, Montefiore Medical Center Epilepsy Management Center, Bronx, NY 10461, USA. ladof@ix.netcom.com
Insights
Gabapentin (GBP) shows anticonvulsant effects in young rats at low doses. Higher doses impair motor performance, but therapeutic potential exists for seizure control in immature animals.
Area of Science:
- Neuroscience
- Pharmacology
- Developmental Biology
Background:
- Epilepsy is a common neurological disorder characterized by recurrent seizures.
- Gabapentin (GBP) is an anticonvulsant medication used to treat epilepsy and neuropathic pain.
- The efficacy and safety of GBP in immature animal models require further investigation.
Purpose of the Study:
- To evaluate the anticonvulsant and motor effects of gabapentin (GBP) in 16-17-day-old rat pups.
- To determine the effective dose range of GBP for preventing kindled seizures in immature rats.
- To assess the potential for motor impairment associated with GBP treatment in this age group.
Main Methods:
- Kindled seizures were induced in 14-day-old rat pups via amygdala electrical stimulation.
- On day 17, pups received varying doses of GBP (10, 25, 50, or 100 mg/kg).
- Seizure prevention was assessed by electrical stimulation post-GBP administration.
- Motor performance was evaluated using a balance beam test in a separate group of rats.
Main Results:
- Gabapentin demonstrated anticonvulsant effects at doses as low as 10 mg/kg.
- Motor performance impairment was observed at doses of 50 mg/kg and above.
- GBP effectively prevented kindled seizures at doses that did not significantly affect motor function.
Conclusions:
- Gabapentin exhibits significant anticonvulsant properties in immature rats.
- The therapeutic window for GBP in young animals allows for seizure control without substantial motor deficits.
- These findings suggest gabapentin's potential as a treatment for seizures in developing individuals.
Abstract:
The anticonvulsant and motor effects of gabapentin (GBP) were evaluated in rat pups aged 16-17 days. Fourteen-day-old rat pups received an implanted stimulating electrode in the amygdala unilaterally. Kindled seizures were produced on day 16 of life by repeatedly applying an electrical current stimulus to the amygdala electrode. Animals received kindling stimulation until they achieved three consecutive generalized convulsions. On day 17, rat pups received one of four doses of GBP 10, 25, 50, or 100 mg/kg. After receiving GBP, rat pups again received electrical stimulation to the amygdala electrode to determine the extent to which GBP prevented the kindled seizure. Anticonvulsant effects were found at doses as low as 10 mg/kg. A separate group of naïve rats received GBP to determine the motor effects of each treatment dose. Impaired motor performance, quantified as time on a balance beam, occurred at doses of >or=50 mg/kg. In summary, our data indicate that in immature rats, GBP exerts an anticonvulsant effect against kindled seizures at doses that do not significantly impair motor performance.